Evidence map›Paper›PMID 34889689›Full record

ArticleBioengineered2021

Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.

Yong Chen, Dong Wang, Tao Shu, Kangwei Sun, Jianbo Zhao, Min Wang, Yi Huang, Ping Wang, Hang Zheng, Zhixuan Cai and 1 more

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Circular RNAs and Cancers.Advances in experimental medicine and biology · 2025
    Review
  4. Computational and structural biotechnology journal · 2024
    Review
  5. Review
  6. Review
  7. Bladder cancer: non-coding RNAs and exosomal non-coding RNAs.Functional & integrative genomics · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yong ChenDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Dong WangDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Tao ShuDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Kangwei SunDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Jianbo ZhaoDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Min WangDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Yi HuangDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Ping WangDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Hang ZhengDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Zhixuan CaiDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Zengyue YangDepartment of Urology Surgery, Xi'an International Medical Center Hospital, Xi'an, China.ORCID 0000-0001-9496-9047

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) play a pivotal regulatory role in bladder cancer (BC) occurrence and progression. The expression level, role and mechanism of circ_0000326 in BC remain unknown. In the present study, quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was conducted to evaluate the expressions of circ_0000326, microRNA-338-3p (miR-338-3p) and ETS Proto-Oncogene 1(ETS1) mRNA in BC tissues and cell lines. Cell counting kit-8 (CCK-8) assay, wound healing assay and flow cytometry were used to detect the impacts of circ_0000326 on BC cell growth, migration and apoptosis. Western blot was used to detect the expressions of ETS1, phospho-phosphoinositide-3 kinase (p-PI3K), phospho-AKT, PI3K and AKT protein. Gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to analyze the biological function of ETS1 in BC. Here, we found that circ_0000326 expression was significantly elevated in BC cell lines and tissues, and circ_0000326 could promote BC cell growth and migration, and inhibit apoptosis. Dual-luciferase reporter gene assay confirmed that circ_0000326 and ETS1 could bind directly to miR-338-3p. Furthermore, circ_0000326 sponged miR-338-3p and up-regulated ETS1 expression. ETS1 was associated with the activation of PI3K/AKT pathway. Moreover, circ_0000326 could activate PI3K/AKT pathway by miR-338-3p/ETS1 axis. Collectively, circ_0000326/miR-338-3p/ETS1/PI3K/AKT pathway is involved in regulating BC progression.

Indexed as

Disease ProgressionApoptosisBase SequenceCell Line, TumorCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMaleMicroRNAsMiddle AgedPhosphatidylinositol 3-KinasesProto-Oncogene Protein c-ets-1Proto-Oncogene Proteins c-aktRNA, CircularETS1 protein, humanMicroRNAsMIRN338 microRNA, humanPhosphatidylinositol 3-KinasesProto-Oncogene Protein c-ets-1Proto-Oncogene Proteins c-aktRNA, Circularbladder cancerCirc_0000326ETS1miR-338-3pPI3K/AKT

Identifiers

PMID34889689
PMCPMC8810167
OpenAlexW4200117616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.